Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Aktuelle Urologie
|
August 24, 2021
[Current treatment options for recurrent/metastatic renal cell carcinoma (mRCC)]
Isabel Virchow, Viktor Grünwald
Der Radiologe
|
February 14, 2020
[What does the nonradiologist expect from the radiologist?]
Stefan Kasper, Isabel Virchow, Boris Hadaschik, et al.
HNO
|
January 13, 2019
[Immuno-oncology of head and neck tumors]
Stefan Kasper, Timon Hussain, Isabel Virchow, et al.
International Journal of Medical Informatics
|
May 27, 2019
Natural language processing of German clinical colorectal cancer notes for guideline-based treatment evaluation
Matthias Becker, Stefan Kasper, Britta Böckmann, et al.
Applied Clinical Informatics
|
March 19, 2020
Mapping Patient Data to Colorectal Cancer Clinical Algorithms for Personalized Guideline-Based Treatment
Matthias Becker, Britta Böckmann, Karl-Heinz Jöckel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2024
Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies
Gregor Zaun, Sabrina Borchert, Martin Metzenmacher, et al.
Oncology Research and Treatment
|
January 9, 2023
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)
Isabel Virchow, Jürgen-Walter Treckmann, Nicole Prasnikar, et al.
Thoracic Cancer
|
March 21, 2025
ABO-Blood Group Associates With Survival Outcomes in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy
Franziska Certa, Peter A Horn, Julius Keyl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 2024
PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors
Tanja Abu Sabbah, Sarah Theurer, Hideo Andreas Baba, et al.
Clinical Colorectal Cancer
|
March 13, 2018
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
Marcel Wiesweg, Henning Reis, Tobias Köster, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Aktuelle Urologie
|
August 24, 2021
[Current treatment options for recurrent/metastatic renal cell carcinoma (mRCC)]
Isabel Virchow, Viktor Grünwald
Der Radiologe
|
February 14, 2020
[What does the nonradiologist expect from the radiologist?]
Stefan Kasper, Isabel Virchow, Boris Hadaschik, et al.
HNO
|
January 13, 2019
[Immuno-oncology of head and neck tumors]
Stefan Kasper, Timon Hussain, Isabel Virchow, et al.
International Journal of Medical Informatics
|
May 27, 2019
Natural language processing of German clinical colorectal cancer notes for guideline-based treatment evaluation
Matthias Becker, Stefan Kasper, Britta Böckmann, et al.
Applied Clinical Informatics
|
March 19, 2020
Mapping Patient Data to Colorectal Cancer Clinical Algorithms for Personalized Guideline-Based Treatment
Matthias Becker, Britta Böckmann, Karl-Heinz Jöckel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2024
Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies
Gregor Zaun, Sabrina Borchert, Martin Metzenmacher, et al.
Oncology Research and Treatment
|
January 9, 2023
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)
Isabel Virchow, Jürgen-Walter Treckmann, Nicole Prasnikar, et al.
Thoracic Cancer
|
March 21, 2025
ABO-Blood Group Associates With Survival Outcomes in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy
Franziska Certa, Peter A Horn, Julius Keyl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 2024
PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors
Tanja Abu Sabbah, Sarah Theurer, Hideo Andreas Baba, et al.
Clinical Colorectal Cancer
|
March 13, 2018
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
Marcel Wiesweg, Henning Reis, Tobias Köster, et al.
Page
of 2